Edwards Carladenise Armbrister 4

What Happened

• Carladenise Armbrister, a director of Clover Health Investments, sold 67,160 shares on May 18, 2026. The reported weighted-average sale price was $3.42 per share, for total proceeds of approximately $229,687. The filing lists the transaction as an open-market or private sale (code S).

Key Details

• Transaction date: 2026-05-18; filing date: 2026-05-19 (filed within the Form 4 reporting window).
• Price: weighted average $3.42; individual sale prices ranged from $3.41 to $3.43 (see footnote).
• Shares sold: 67,160; proceeds: ~$229,687.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: The price reported is a weighted average; the reporting person can provide the number of shares sold at each separate price on request.
• No 10b5‑1 plan, option exercise, gift, or tax‑withholding notation is indicated in the provided transaction details.

Context

• This was a sale (not a purchase or option exercise). Sales by insiders can be routine liquidity events and do not by themselves indicate the insider’s view of the company’s prospects. Because this filing reports an open-market sale by a director and was filed promptly, it shows standard insider disclosure rather than a special corporate action.